Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Balaxi Pharmaceuticals Limited ( (IN:BALAXI) ) is now available.
Balaxi Pharmaceuticals Limited has submitted a certificate to the National Stock Exchange of India, confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ending June 30, 2025. This compliance involves the dematerialization of securities, ensuring that securities are listed on the appropriate stock exchanges, and updating records to reflect the depository as the registered owner, which is crucial for maintaining regulatory standards and operational transparency.
More about Balaxi Pharmaceuticals Limited
Balaxi Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is engaged in providing a range of healthcare solutions and is listed on the National Stock Exchange of India.
Average Trading Volume: 336,638
Current Market Cap: 551.7M INR
For an in-depth examination of BALAXI stock, go to TipRanks’ Overview page.